NM_000141.5:c.1009G>C
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM1PM2PP2PP3_ModeratePP5_Very_Strong
The NM_000141.5(FGFR2):c.1009G>C(p.Ala337Pro) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000141.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FGFR2 | ENST00000358487.10 | c.1009G>C | p.Ala337Pro | missense_variant | Exon 8 of 18 | 1 | NM_000141.5 | ENSP00000351276.6 | ||
FGFR2 | ENST00000613048.4 | c.742G>C | p.Ala248Pro | missense_variant | Exon 7 of 17 | 5 | ENSP00000484154.1 | |||
FGFR2 | ENST00000478859.5 | c.325G>C | p.Ala109Pro | missense_variant | Exon 7 of 17 | 1 | ENSP00000474011.1 | |||
FGFR2 | ENST00000457416.7 | c.1087+1288G>C | intron_variant | Intron 8 of 17 | 1 | ENSP00000410294.2 | ||||
FGFR2 | ENST00000369056.5 | c.1087+1288G>C | intron_variant | Intron 7 of 16 | 1 | ENSP00000358052.1 | ||||
FGFR2 | ENST00000369058.7 | c.1087+1288G>C | intron_variant | Intron 8 of 16 | 1 | ENSP00000358054.3 | ||||
FGFR2 | ENST00000369061.8 | c.749-2075G>C | intron_variant | Intron 5 of 14 | 1 | ENSP00000358057.4 | ||||
FGFR2 | ENST00000369059.5 | c.742+1288G>C | intron_variant | Intron 6 of 15 | 5 | ENSP00000358055.1 | ||||
FGFR2 | ENST00000360144.7 | c.820+1288G>C | intron_variant | Intron 7 of 16 | 2 | ENSP00000353262.3 | ||||
FGFR2 | ENST00000604236.5 | n.*56G>C | non_coding_transcript_exon_variant | Exon 7 of 17 | 1 | ENSP00000474109.1 | ||||
FGFR2 | ENST00000604236.5 | n.*56G>C | 3_prime_UTR_variant | Exon 7 of 17 | 1 | ENSP00000474109.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Crouzon syndrome Pathogenic:2
- -
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0103 - Loss of function and gain of function are known mechanisms of disease in this gene and are associated with FGFR2-related disorders (PMIDs: 29848297, 32879300, 27323706). (I) 0108 - This gene is associated with both recessive and dominant disease. Autosomal recessive inheritance has only been reported in one family with ectrodactyly and acinar dysplasia (PMID: 27323706). (I) 0115 - Variants in this gene are known to have variable expressivity. Variable expressivity has been reported for Crouzon syndrome (MIM#123500) whereby some relatives can have mild phenotypic manifestations and can seem unaffected (GeneReviews). (I) 0200 - Variant is predicted to result in a missense amino acid change from alanine to proline. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0502 - Missense variant with conflicting in silico predictions and uninformative conservation. (I) 0602 - Variant is located in a hotspot region or cluster of pathogenic variants (DECIPHER). (SP) 0710 - Another missense variant comparable to the one identified in this case has inconclusive previous evidence for pathogenicity. The p.(Ala337Thr) variant has been reported in one individual with left unicoronal synostosis without crouzonoid facies or other syndromic features. The same variant was identified in her unaffected father and five other unaffected relatives, where only one had significant midface hypoplasia (PMID: 17621648). (I) 0802 - This variant has moderate previous evidence of pathogenicity in unrelated individuals. This variant has been reported in three unrelated individuals with Crouzon syndrome (PMIDs: 9677057, 16418739, 25271085). (SP) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1102 - Strong phenotype match for this individual. (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
FGFR2-related craniosynostosis Pathogenic:1
ClinVar contains an entry for this variant (Variation ID: 29853). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FGFR2 protein function. For these reasons, this variant has been classified as Pathogenic. This missense change has been observed in individuals with FGFR2-related conditions (PMID: 9677057, 16418739, 25271085; Invitae). This sequence change replaces alanine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 337 of the FGFR2 protein (p.Ala337Pro). This variant is not present in population databases (gnomAD no frequency). -
not provided Pathogenic:1
Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23754559, 11781872, 29230096, 9677057, 10425034, 17621648, 24656465, 25271085, 35372644, Passos-Bueno2008[chapter]) -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at